Demand for the drugs is unlikely to slow down in 2024, especially as treatments gradually become more accessible. Much of Wall Street believes the weight loss drug market will only expand, with some analysts projecting that it will be worth $100 billion by the end of the decade. Goldman Sachs analysts expect 15 million U.S. adults … Read more
NEW YORK, Nov. 24, 2023 /PRNewswire/ — A latest research report [110+] pages with 360-Degree visibility, titled “Bio Pharma Logistics Market Share, Size, Trends, Industry Analysis Report, By Type (Cold Chain Logistics, Non-Cold Chain Logistics); By Service Type; By Mode of Transportation; By Region; Segment Forecast, 2023- 2032” published by Polaris Market Research in its … Read more
Company also commits to investing up to $100 million in German early-stage life sciences ecosystem INDIANAPOLIS, Nov. 17, 2023 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced plans to construct a new $2.5 billion high-tech manufacturing site in Alzey, Rhineland-Palatinate, Germany. This new facility will further expand the company’s global parenteral (injectable) product … Read more
Prof Cai, Chair in Synthetic Genomics at The University of Manchester who is the international coordinator of Sc2.0 project, said: “This is an exciting milestone when it comes to engineering biology. While we have been able to edit genes for some time, we have never before been able to write a eukaryote genome from scratch. … Read more
In collaboration with leading cancer centers, research results to be presented from seven studies across a breadth of tumor types and genomic alterations demonstrating Caris’ impact on precision medicine IRVING, Texas, Oct. 17, 2023 /PRNewswire/ — Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering … Read more
High-grade serous ovarian carcinoma (HGSOC) is the most common type of ovarian cancer. It is also the most lethal form, in part because clinicians do not have effective ways to screen women for it during the cancer’s early stages, when it’s easiest to treat. For patients with a pelvic mass (an abnormal lump or growth … Read more
Blockbuster weight loss and diabetes drugs like Wegovy and Ozempic may be associated with an increased risk of three rare, but severe, stomach conditions in non-diabetic patients, according to a new study released Thursday. Researchers at the University of British Columbia said the risks include one condition not named in the warning labels for the … Read more
Group 2 data available to date support primary safety and feasibility endpoints of single-day bolus dosing of CT-0508 New translational analyses combining group 1 & group 2 continue to support CAR-M mechanism of action, demonstrating a correlation between biomarkers and best overall response PHILADELPHIA, Sept. 1, 2023 /PRNewswire/ — Carisma Therapeutics Inc. (Nasdaq: CARM) … Read more
COPENHAGEN, Denmark, Aug. 31, 2023 /PRNewswire/ — BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating world-class life science research, today announces that eight new companies have entered its Venture Lab acceleration program for early-stage companies. The cohort is strategically aligned with BII’s focus on supporting innovative early-stage start-ups within human and planetary health. The … Read more
A change in just one letter in the code that makes up a cancer-causing gene can significantly affect how aggressive a tumor is or how well a patient with cancer responds to a particular therapy. A new, very precise gene-editing tool created by Weill Cornell Medicine investigators will enable scientists to study the impact of … Read more